Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone Hydrochloride Injection for Lymphatic Tracing in Radical Gastrectomy
ChiCTR2300073256Phase 3Not yet recruiting
- Sponsor
- The Fourth Hospital of Hebei Medical University
- Start
- Jun 2023
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of mitoxantrone in gastric cancer (GC) and gastric adenocarcinoma (2 arms), sponsored by The Fourth Hospital of Hebei Medical University. Primary endpoint: Lymph node staining rate. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
mitoxantrone
03
Conditions
gastric cancer (GC)gastric adenocarcinoma
Beyond the preview
Go deeper on ChiCTR2300073256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073256.